Skip to main
G

Genpact (G) Stock Forecast & Price Target

Genpact (G) Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 29%
Buy 0%
Hold 71%
Sell 0%
Strong Sell 0%

Bulls say

Genpact is expected to gradually improve its performance in FY26 as macro conditions stabilize, and its margins will continue to improve through efficiency gains. The company has a strong demand for its core BPO and analytics services, with potential upside to estimates given the healthy deal pipeline and strong demand for AI-based solutions. With an inexpensive trading price at ~7x the FY27 EPS estimate, the risk-reward for investors is attractive and Genpact offers a strong opportunity for both offense and defense with its focus on streamlining operations and reducing costs for Global 2000 firms.

Bears say

Genpact is a financially stable company with strong cash reserves and a solid track record of returning value to shareholders. However, potential issues with employee retention and economic downturns may hinder revenue growth and result in a decrease in the company's stock multiple. A positive outlook for Genpact's core business services could lead to higher growth and a potential increase in the stock multiple.

Genpact (G) has been analyzed by 7 analysts, with a consensus rating of Buy. 29% of analysts recommend a Strong Buy, 0% recommend Buy, 71% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Genpact and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Genpact (G) Forecast

Analysts have given Genpact (G) a Buy based on their latest research and market trends.

According to 7 analysts, Genpact (G) has a Buy consensus rating as of Jul 26, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $41.57, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $41.57, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Genpact (G)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.